
Congress trades
Sabra Health Care REIT, Inc. (SBRA)
NASDAQ · Real Estate · 8 congress trades · last filed 3 years ago
About Sabra Health Care REIT, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Chief executive
- Richard K. Matros
- Employees
- 58
- Listed since
- Apr 2, 2002
- Market value
- $5.2B
- Price to earnings
- 78.7
- Earnings per share
- $0.26
- Dividend yield
- 5.77%
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 3, 2026 | -$0.10 | $0.17 | $235.9M | $219.4M | EPS missRevenue beat |
| Q1 FY2026reported Apr 29, 2026 | $0.16 | $0.17 | $221.8M | $209.2M | EPS missRevenue beat |
| Q4 FY2025reported Feb 12, 2026 | $0.11 | $0.17 | $211.9M | $198.0M | EPS missRevenue beat |
| Q3 FY2025reported Nov 5, 2025 | $0.09 | $0.18 | $190.0M | $186.8M | EPS missRevenue beat |
| Q2 FY2025reported Aug 4, 2025 | $0.28 | $0.18 | $189.2M | $180.9M | EPS beatRevenue beat |
| Q1 FY2025reported May 5, 2025 | $0.17 | $0.17 | $183.5M | $179.0M | EPS missRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 24, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Richard K. MatrosChief Executive Officer, President & Chair of the Boar | $1.0M | $5.0M | $2.5M | $8.6M |
| Michael L. CostaChief Financial Officer, Executive Vice President & Tr | $645K | $2.0M | $1.1M | $3.8M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $811.9M | 41,614,351 | +6.4% | 16.50% |
| Principal Financial Group Inc | $482.0M | 24,706,070 | -1.4% | 9.79% |
| Vanguard Portfolio Management LLC | $455.6M | 23,352,373 | +0.9% | 9.26% |
| State Street Corp | $240.1M | 12,305,655 | +1.7% | 4.88% |
| Vanguard Capital Management LLC | $221.4M | 11,349,125 | +1.1% | 4.50% |
| Geode Capital Management, LLC | $154.3M | 7,909,172 | +6.2% | 3.14% |
| Centersquare Investment Management LLC | $113.4M | 5,814,427 | +49.9% | 2.30% |
| Bank Of America Corp | $103.4M | 5,300,762 | -2.0% | 2.10% |
| Charles Schwab Investment Management Inc | $94.4M | 4,840,401 | +1.4% | 1.92% |
| Sixth Street Partners Management Company, L.P. | $94.4M | 4,840,401 | +100.0% | 1.92% |
| Nuveen, LLC | $87.1M | 4,464,764 | -33.1% | 1.77% |
| Lasalle Investment Management Securities LLC | $83.5M | 4,278,884 | +11.9% | 1.70% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Congress trades in SBRA
8 disclosures of 8 on record · median 39d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Daniel S. Goldman | Stock | Sale | $1,001 - $15,000 | +80.0%S&P +86.2% · vs S&P 500 -6.2% | Apr 10, 2023 | May 19, 2023 | 39d |
| Daniel S. GoldmanFiled late | Stock | Purchase | $1,001 - $15,000 | +76.2%S&P +93.2% · vs S&P 500 -17.0% | Mar 1, 2023 | Apr 17, 2023 | 47d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +19.1%S&P +177.8% · vs S&P 500 -158.7% | Mar 8, 2019 | Mar 27, 2019 | 19d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +16.9%S&P +173.8% · vs S&P 500 -156.8% | Mar 11, 2019 | Mar 27, 2019 | 16d |
| Gary J. PalmerJointFiled late | Stock | Purchase | $1,001 - $15,000 | -8.7%S&P +173.6% · vs S&P 500 -182.3% | Jul 12, 2018 | Sep 29, 2018 | 79d |
| Gary J. PalmerFiled late | Stock | Purchase | $1,001 - $15,000 | -6.2%S&P +168.3% · vs S&P 500 -174.5% | Aug 6, 2018 | Sep 29, 2018 | 54d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | -5.1%S&P +202.5% · vs S&P 500 -207.5% | Oct 2, 2017 | Nov 3, 2017 | 32d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | -5.2%S&P +203.7% · vs S&P 500 -209.0% | Sep 29, 2017 | Nov 3, 2017 | 35d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded SBRA?
Daniel S. Goldman, Lois Frankel, Gary J. Palmer disclosed SBRA transactions in the filings shown here.
How quickly are SBRA trades disclosed?
Congressional disclosures took a median of 39 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
